Improvement of insulin sensitivity by antagonism of the renin-angiotensin system
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
The reduced capacity of insulin to stimulate glucose transport into skeletal muscle, termed insulin resistance, is a primary defect leading to the development of prediabetes and overt type 2 diabetes. Although the etiology of this skeletal muscle insulin resistance is multifactorial, there is accumulating evidence that one contributor is overactivity of the renin-angiotensin system (RAS). Angiotensin II (ANG II) produced from this system can act on ANG II type 1 receptors both in the vascular endothelium and in myocytes, with an enhancement of the intracellular production of reactive oxygen species (ROS). Evidence from animal model and cultured skeletal muscle cell line studies indicates ANG II can induce insulin resistance. Chronic ANG II infusion into an insulin-sensitive rat produces a markedly insulin-resistant state that is associated with a negative impact of ROS on the skeletal muscle glucose transport system. ANG II treatment of L6 myocytes causes impaired insulin receptor substrate (IRS)-1-dependent insulin signaling that is accompanied by augmentation of NADPH oxidase-mediated ROS production. Further critical evidence has been obtained from the TG(mREN2)27 rat, a model of RAS overactivity and insulin resistance. The TG(mREN2)27 rat displays whole body and skeletal muscle insulin resistance that is associated with local oxidative stress and a significant reduction in the functionality of the insulin receptor (IR)/IRS-1-dependent insulin signaling. Treatment with a selective ANG II type 1 receptor antagonist leads to improvements in whole body insulin sensitivity, enhanced insulin-stimulated glucose transport in muscle, and reduced local oxidative stress. In addition, exercise training of TG(mREN2)27 rats enhances whole body and skeletal muscle insulin action. However, these metabolic improvements elicited by antagonism of ANG II action or exercise training are independent of upregulation of IR/IRS-1-dependent signaling. Collectively, these findings support targeting the RAS in the design of interventions to improve metabolic and cardiovascular function in conditions of insulin resistance associated with prediabetes and type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561
Aguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487 · cited 1×
“The protein expression and functionality of IR and IRS-1 can be negatively regulated by serine/threonine phosphorylation (1, 2, 5, 6, 51, 52, 62, 66, 71).”
BackgroundGlucose Transporters and Insulin Action — Implications for Insulin Resistance and Diabetes Mellitus
Shepherd, P. R., & Kahn, B. B. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907223410406 · Cited by 1,295
Kohn, A. D., Summers, S. A., Birnbaum, M. J., & Roth, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31372 · Cited by 1,284 · cited 1×
“Akt is one downstream target of PDK, and this serine/threonine kinase appear to be critical in the regulation of glucose transport (20, 33, 67), although a limited number of studies do not support this concept (32).”
BackgroundAguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m101521200 · Cited by 1,010 · cited 1×
“The protein expression and functionality of IR and IRS-1 can be negatively regulated by serine/threonine phosphorylation (1, 2, 5, 6, 51, 52, 62, 66, 71).”
BackgroundZierath, J. R., He, L., Gumà, A., Wahlström, E. O., Klip, A., & Wallberg-Henriksson, H. (1996) · Diabetologia · doi:10.1007/bf02658504 · Cited by 402 · cited 1×
“In skeletal muscle from subjects with the “cardiometabolic syndrome” and overt type 2 diabetes, insulin-stimulated tyrosine phosphorylation of IR and IRS-1 and activation of PI3kinase and Akt are reduced (3, 18, 34, 35), leading to defects in GLUT-4 translocation to the sarcolemmal membrane (57, 72).”
BackgroundKrook, A., Björnholm, M., Galuska, D., Jiang, X. J., Fahlman, R., Myers, M. G., Wallberg-Henriksson, H., & Zierath, J. R. (2000) · Diabetes · doi:10.2337/diabetes.49.2.284 · Cited by 375 · cited 1×
“In skeletal muscle from subjects with the “cardiometabolic syndrome” and overt type 2 diabetes, insulin-stimulated tyrosine phosphorylation of IR and IRS-1 and activation of PI3kinase and Akt are reduced (3, 18, 34, 35), leading to defects in GLUT-4 translocation to the sarcolemmal membrane (57, 72).”
BackgroundEnergy-sensing and signaling by AMP-activated protein kinase in skeletal muscle
Winder, W. W. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.3.1017 · Cited by 375
Insulin action and insulin resistance in human skeletal muscle
Zierath, J. R., Krook, A., & Wallberg-Henriksson, H. (2000) · Diabetologia · doi:10.1007/s001250051457 · Cited by 367
Cited by
Oxidative stress and the etiology of insulin resistance and type 2 diabetes
Henriksen, E. J., Diamond-Stanic, M. K., & Marchionne, E. M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.005 · Cited by 600
“Overactivity of the renin-angiotensin system is linked not only with the multifactorial etiology of hypertension, but is also known to be associated with the development of skeletal muscle insulin resistance and type 2 diabetes [29,30].”
BackgroundSelf-citationEndothelial dysfunction in diabetes mellitus: Molecular mechanisms and clinical implications
Tabit, C. E., Chung, W. B., Hamburg, N. M., & Vita, J. A. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9134-4 · Cited by 572
Angiotensin II and the development of insulin resistance: Implications for diabetes
Olivares-Reyes, J. A., Arellano-Plancarte, A., & Castillo-Hernandez, J. R. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.12.011 · Cited by 202
Lamb, R. E., & Goldstein, B. J. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01789.x · Cited by 165
Modulation of glucose metabolism by the renin-angiotensin-aldosterone system
Favre, G. A., Esnault, V. L. M., & Van Obberghen, E. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00391.2014 · Cited by 114
Relation of aging and sex hormones to metabolic syndrome and cardiovascular disease
Guarner-Lans, V., Rubio-Ruiz, M. E., Pérez-Torres, I., & Baños de MacCarthy, G. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2011.02.007 · Cited by 102
Perinatal Exposure to Western Diet Programs Autonomic Dysfunction in the Male Offspring
Mukerjee, S., Zhu, Y., Zsombok, A., Mauvais-Jarvis, F., Zhao, J., & Lazartigues, E. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-017-0502-4 · Cited by 18
Metadata
- Authors
- Henriksen, E. J.
- Venue
- American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Publisher
- American Physiological Society
- Published
- 2007-09
- Volume
- 293
- Issue
- 3
- Pages
- R974-R980
- ISSN
- 0363-6119 (ISSN-L)
- 1522-1490
- OpenAlex
- W2131927337
- Cited by
- 123
- References
- 18
- FWCI
- 6.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.